OOIR: Observatory of International Research

Papers

(The TQCC of Current Hematologic Malignancy Reports is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations	171
Targeting RUNX1 Germline Variants: Agents Under Investigation	36
Monoclonal Gammopathy-Associated Neuropathy	27
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions	25
Management of Chronic Myeloid Leukemia in Children and Young Adults	22
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease	22
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications	20
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities	20
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations	20
Value in Myeloma Care: Myth or Reality	19
Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications	19
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer	19
Allogeneic Transplant for CMML	18
Transplantation and Cellular Therapy for Older Adults—The MSK Approach	18
How Do We Manage Chronic Lymphocytic Leukemia in India	15
Prognostic and Predictive Models in Myelofibrosis	15
Multiple Myeloma: Current Clinical Landscape and Compounding Costs	14
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications	13
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia	13
Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders	13
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults	13
Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies	12
Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Development	12
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia	11
Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders	11

Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia	9
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies	9